MSH|^~\&|LAB|ARH|||202002120926||ORU^R01|4166280|D|2.3|||AL|NE
PID|1||AB00007803|PA2506|LABTEST^ALLOSAURUS^||19851121|F||||||||||AB000896/18|9875619677
OBR|1|39278^LAB|00029632^1202:C00006R^LAB^120220:C6^39278|499.0052^QCOWCARM2^QC ONE WORLD CARDIAC MARKERS 2^^^||202002120907|202002120907|||||||202002120907||||||||||LAB|F||||
OBX|1|ST|500.5630^BNPNT R^NT-Pro-B Type Nat Peptide^^33762-6^33762-6|1|250^^Y|ng/L|<300|N||A^S|F|||202002120908
NTE|1||Heart failure is unlikely if NT-Pro BNP is <300 ng/L.
NTE|2||
NTE|3||Heart failure is likely if:
NTE|4||     NT-Pro BNP >450 ng/L for patients <50 years of age
NTE|5||     NT-Pro BNP >900 ng/L for patients 50-75 years of age
NTE|6||     NT-Pro BNP >1800 ng/L for patients >75 years of age
OBX|2|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|5.0^^Y|mg/L|<7.5|N||A^S|F|||202002120908
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.